Involvement of Cytochromes P450 2D6, 2B6 and 2C19 in the Metabolism of (-)-Deprenyl and N-Methyl,N-propargylphenylethylamine

Author(s): K. A. Rittenbach, G. B. Baker

Journal Name: Drug Metabolism Letters

Volume 1 , Issue 2 , 2007

Become EABM
Become Reviewer
Call for Editor


The metabolism of (-)-deprenyl (N-methyl,N-propargylamphetamine) and N-methyl,N-propargylphenylethylamine (MPPE), monoamine oxidase inhibitors with neuroprotective properties, was studied using human liver microsomes and cDNA-expressed cytochrome P450 (CYP) enzymes. The metabolic pathways of MPPE parallel those of (-)- deprenyl, but some marked differences were observed, particularly with regard to the contributions of CYP2B6 and CYP2D6.

Keywords: amphetamine, CYP2B6, propargylamphetamine, cDNA, Metabolism

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [97 - 100]
Pages: 4
DOI: 10.2174/187231207780363589
Price: $58

Article Metrics

PDF: 5